Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8857)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2022 (publication date) through Oct 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [PMID: 35116109 DOI: 10.4251/wjgo.v14.i1.163] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [PMID: 35116109 DOI: 10.4251/wjgo.v14.i1.163] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i1/163.htm |
| Number | Citing Articles |
| 1 |
Arno Kornberg, Linda Kaschny, Jennifer Kornberg, Helmut Friess. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Journal of Hepatocellular Carcinoma 2022; : 649 doi: 10.2147/JHC.S366107
|
| 2 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|
| 3 |
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti. Main factors influencing long-term outcomes of liver transplantation in 2022. World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
|
| 4 |
Tian Song, Kan-Hua Wu, Hao Yang, Wen-Li Xie, Lan Shen. Multidisciplinary treatment strategies for the assessment of immune, coagulation, and biomarker responses after transarterial chemoembolization for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2025; 17(5): 101605 doi: 10.4240/wjgs.v17.i5.101605
|
| 5 |
Miho Akabane, Yuki Imaoka, Jun Kawashima, Austin Schenk, Timothy M. Pawlik. Immunotherapy in liver transplantation for hepatocellular carcinoma: A comprehensive review. Journal of Liver Transplantation 2025; 17: 100256 doi: 10.1016/j.liver.2024.100256
|
| 6 |
Luyu Li, Yaorui Hu, Xiao Li, Baojun Ju. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review. Medicine 2024; 103(15): e37688 doi: 10.1097/MD.0000000000037688
|
| 7 |
Maneerat Chayanupatkul, Thomas D. Schiano. Hepatology. 2025; : 1261 doi: 10.1016/B978-0-443-26711-6.00043-3
|
| 8 |
Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen. Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition). Liver Cancer 2024; 13(4): 355 doi: 10.1159/000535496
|
| 9 |
Dalal Alhaqqan, Yii Chun Khiew, Maryam Dadashzadeh, Aiwu Ruth He, Arul Thomas, Amol Rangnekar. Harnessing the Power of Immunotherapy in Liver Transplantation for HCC. Current Transplantation Reports 2024; 11(3): 131 doi: 10.1007/s40472-024-00439-3
|
| 10 |
Shaobo Zhang, Shugeng Zhang. Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report. Transplantation Proceedings 2025; 57(4): 580 doi: 10.1016/j.transproceed.2025.02.041
|
| 11 |
Shabana Begum, Pranab Behari Mazumder, Anupam Das Talukdar. In vitro evaluation of anticancer activity of Oxalis corniculata L., by harnessing exosome for effective drug delivery against hepatocellular carcinoma. Pharmacological Research - Natural Products 2025; 8: 100298 doi: 10.1016/j.prenap.2025.100298
|
| 12 |
Carrie E. Ryan, Jacob Lambdin, Shimul Shah, Ralph Cutler Quillin, Kristina Lemon, Jonathan M. Hernandez, Davendra Sohal. Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant. Annals of Surgical Oncology 2023; 30(2): 686 doi: 10.1245/s10434-022-12811-7
|
| 13 |
Parissa Tabrizian, Marcus Zeitlhoefler, Ahmed Talaat Hassan, Rebecca Marino. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy. Current Opinion in Organ Transplantation 2024; 29(2): 144 doi: 10.1097/MOT.0000000000001133
|
| 14 |
Miho Akabane, Odysseas Chatzipanagiotou, Yuki Imaoka, Austin Schenk, Timothy Pawlik. Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review. ImmunoTargets and Therapy 2025; : 631 doi: 10.2147/ITT.S528709
|
| 15 |
Francesca Salani, Virginia Genovesi, Caterina Vivaldi, Valentina Massa, Silvia Cesario, Laura Bernardini, Miriam Caccese, Jessica Graziani, Dario Berra, Lorenzo Fornaro, Gianluca Masi. Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle. Cancers 2022; 14(19): 4896 doi: 10.3390/cancers14194896
|
| 16 |
Maciej Gryziak, Krzysztof Wozniak, Leszek Kraj, Letycja Rog, Rafal Stec. The immune landscape of hepatocellular carcinoma‑where we are? (Review). Oncology Letters 2022; 24(5) doi: 10.3892/ol.2022.13530
|
| 17 |
|
| 18 |
Anran Liu, Jiang Zhang, Tong Li, Danyang Zheng, Yihong Ling, Lianghe Lu, Yuanpeng Zhang, Jing Cai. Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma. Hepatology International 2025; 19(4): 866 doi: 10.1007/s12072-025-10793-8
|
| 19 |
Kevin Tak-Pan Ng, Jiang Liu, Oscar Wai-Ho Yeung, Li Pang, Hoi Chung Shiu, Hui Liu, Xin Xiang Yang, Albert Chi-Yan Chan, Tiffany Cho-Lam Wong, Chung Mau Lo, Kwan Man. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Hepatology International 2023; 17(6): 1596 doi: 10.1007/s12072-023-10566-1
|
| 20 |
Wanyue Cao, Jing Lu, Shanbao Li, Fangbin Song, Junming Xu. Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.947437
|
| 21 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
| 22 |
Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, Naomy Kim, Hasmik Adetyan, Nguyen H. Tran, Ju Dong Yang. Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03226-3
|